logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Bendamustine/obinutuzumab/rituximabCOVID-19 infection and prolonged COVID-19 virus positivity: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1922卷 / 1期
关键词:
D O I:
10.1007/s40278-022-22419-7
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:134 / 134
相关论文
共 50 条
  • [1] Remdesivir/rituximabCOVID-19 infection and COVID-19 infection rebound: case report
    Reactions Weekly, 2022, 1927 (1) : 461 - 461
  • [2] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2024, 2023 (1) : 360 - 360
  • [3] Bendamustine/rituximabCOVID-19 pneumonia: case report
    Reactions Weekly, 2021, 1861 (1) : 72 - 72
  • [4] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2021, 1878 (1) : 463 - 463
  • [5] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2021, 1857 (1) : 304 - 304
  • [6] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2022, 1909 (1) : 486 - 486
  • [7] RituximabCOVID-19 infection : case report
    Reactions Weekly, 2024, 2018 (1) : 409 - 409
  • [8] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2025, 2051 (1) : 285 - 285
  • [9] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2023, 1959 (1) : 576 - 576
  • [10] RituximabCOVID-19 infection: case report
    Reactions Weekly, 2023, 1963 (1) : 459 - 459
← 12345 →